Standex International Corp/de/ Form 4 insider transactions

Insider transactions: buys and sells by directors, officers and ten percent owners, filed within two business days of the trade.

NYSE
Richard Colby Slaughter, CLO, VP and Secretary of Standex International Corp/De/, received 2,285 shares of common stock on August 10, 2026.
NYSE
Thomas E Chorman, a Director of Standex International Corp/De/, sold 50 shares of common stock on August 3, 2026 for $305.56 per share.
NYSE
Standex International Corp reports an award of Restricted Stock Units to Vice President/CFO/Treasurer Ademir Sarcevic.
NYSE
Thomas E. Chorman, a Director at Standex International Corp., reported a sale of 50 shares of common stock on July 1, 2026, executed under a pre-existing 10b5-1 trading plan.
NYSE
Director Barbara Joanne Edwards gifted 150 shares of Standex International Corp common stock to a charitable donor advised fund.
NYSE
Thomas E. Chorman, a Director at Standex International Corp., has sold 50 shares of common stock as part of a pre-arranged trading plan.
NYSE
Standex International Corporation Director Barbara Joanne Edwards sold 558 shares of common stock on May 27, 2026.
NYSE
Danielle Rangel, VP & Chief Accounting Officer of Standex International Corp, was granted 603 Restricted Stock Units under the company's 2018 Omnibus Incentive Plan.
NYSE
Thomas E. Chorman, a Director at Standex International Corp., has reported the sale of 50 shares of common stock.
NYSE
Max Arets, VP and Chief Information Officer of Standex International Corp., reported a transaction involving the forfeiture of 132 shares to cover tax liabilities related to vesting restricted stock.
NYSE
Alan J. Glass, CLO, VP & Secretary of Standex International Corp, reported a transaction involving the forfeiture of 204 shares of common stock on April 2, 2026, to cover tax liabilities.
NYSE
Standex International reports that Vice President, CFO, and Treasurer Ademir Sarcevic forfeited 1,713 shares of common stock to cover tax liabilities related to restricted stock vesting.
NYSE
Standex International Director Thomas E. Chorman reported a sale of 50 shares of common stock on April 1, 2026, executed under a pre-existing 10b5-1 trading plan.
NYSE
Standex International Director Thomas E. Chorman reported the sale of 50 common shares at $259 each, executed under a pre-arranged 10b5-1 trading plan.
NYSE
Standex International Director Thomas E. Chorman filed a Form 4 disclosing a planned sale of 513 common shares on February 27, 2026, under a Rule 10b5-1 trading plan.
NYSE
Standex International Corp. Director Barbara Joanne Edwards reported gifting 58 shares of common stock, reducing her direct beneficial ownership to 6,227 shares.
NYSE
Standex International's Chief Strategy Officer, Vineet Kshirsagar, sold 400 shares of common stock for $260.10 per share under a pre-arranged trading plan.
NYSE
Standex International Director Thomas E. Chorman sold 50 shares of common stock for $249.86 per share under a pre-arranged 10b5-1 plan.
NYSE
A Standex International director plans to acquire 2,000 shares of common stock at $245 per share in a pre-arranged transaction set for February 4, 2026.
NYSE
Standex International Director Charles H. Cannon Jr. transferred 1,295 shares of common stock to a family trust, as reported in a Form 4 filing.
NYSE
Standex International Director Thomas E. Chorman reported selling 1,000 shares of common stock for $223.31 per share on November 20, 2025, under a Rule 10b5-1 plan.
NYSE
Standex International Director Andy L. Nemeth amended a Form 4 to correct a reported stock acquisition to an open market purchase of 1,500 shares at $205.
NYSE
Standex International Director Andy Nemeth amended a Form 4 filing to correct the transaction code for a purchase of 2,000 shares of common stock.
NYSE
Standex International's Chief HR Officer, Michelle Newbury, was granted restricted stock, phantom stock units, and restricted stock units as part of the company's incentive plan.
NYSE
Standex International's Chief Strategy Officer, Vineet Kshirsagar, reported the sale of 650 shares of common stock for approximately $233.37 per share.
NYSE
Standex International's VP/CFO/Treasurer, Ademir Sarcevic, sold 1,823 shares of common stock for approximately $230.12 per share under a pre-arranged Rule 10b5-1 plan.
NYSE
Standex International's VP, Chief HR Officer, Annemarie Bell, forfeited 111 shares of common stock to cover tax liabilities related to restricted stock vesting.
NYSE
Standex International Director Thomas E. Chorman was granted 639 shares of common stock as restricted stock, vesting in three years.
NYSE
Standex International Director Michael A. Hickey was granted 639 shares of restricted common stock, vesting in three years.
NYSE
Standex International Director Jeffrey S. Edwards was granted 639 shares of restricted common stock, vesting in three years, under the company's 2018 Omnibus Incentive Plan.